{
    "clinical_study": {
        "@rank": "26564", 
        "acronym": "VITAL-Cog", 
        "arm_group": [
            {
                "arm_group_label": "Vitamin D + fish oil", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Vitamin D + fish oil placebo", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Vitamin D placebo + fish oil", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Vitamin D placebo + fish oil placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) is an ongoing randomized clinical\n      trial in 25,875 U.S. men and women investigating whether taking daily dietary supplements of\n      vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor\u00ae fish oil, 1 gram) reduces the risk of\n      developing cancer, heart disease, and stroke in people who do not have a prior history of\n      these illnesses. This ancillary study is being conducted among participants in VITAL and\n      will examine whether vitamin D or fish oil is associated with cognitive decline in 3000\n      older participants of VITAL."
        }, 
        "brief_title": "A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline", 
        "completion_date": {
            "#text": "October 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Cognitive Decline", 
        "condition_browse": {
            "mesh_term": "Cognition Disorders"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Participants in VITAL (NCT 01169259) who meet the following criteria are eligible to\n        participate in this ancillary study:\n\n          1. are aged 60 or more\n\n          2. have no hearing impairment\n\n          3. provide a blood sample or fill out a food frequency questionnaire in the run-in\n             period\n\n          4. indicate a willingness on the run-in phase to participate in a cognitive sub-study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "60 Years"
        }, 
        "enrollment": {
            "#text": "3226", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01669915", 
            "org_study_id": "2010P-000769", 
            "secondary_id": "R01AG036755"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Vitamin D + fish oil", 
                    "Vitamin D + fish oil placebo"
                ], 
                "description": "Vitamin D3 (cholecalciferol), 2000 IU per day", 
                "intervention_name": "vitamin D3", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "cholecalciferol"
            }, 
            {
                "arm_group_label": [
                    "Vitamin D + fish oil", 
                    "Vitamin D placebo + fish oil"
                ], 
                "description": "Omacor, 1 capsule per day. Each capsule of Omacor contains 840 milligrams of marine omega-3 fatty acids (465 mg of eicosapentaenoic acid [EPA] and 375 mg of docosahexaenoic acid [DHA]).", 
                "intervention_name": "omega-3 fatty acids (fish oil)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Vitamin D placebo + fish oil", 
                    "Vitamin D placebo + fish oil placebo"
                ], 
                "description": "Vitamin D placebo", 
                "intervention_name": "Vitamin D3 placebo", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": [
                    "Vitamin D + fish oil placebo", 
                    "Vitamin D placebo + fish oil placebo"
                ], 
                "description": "Fish oil placebo", 
                "intervention_name": "Fish oil placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cholecalciferol", 
                "Vitamin D", 
                "Ergocalciferols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 29, 2014", 
        "link": {
            "description": "VITAL study website link", 
            "url": "http://www.vitalstudy.org"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts"
                }
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "By telephone, we will administer seven tests of cognitive function (1.Telephone Interview of Cognitive Status (TICS); 2.Delayed recall of the TICS 10-word list; 3.East Boston Memory Test (EBMT); 4.Delayed recall of the EBMT; 5.Category fluency test (animal naming test); 6.Oral Trail Making Test (OTMT); 7.Digit span backwards). These interviews will be repeated every 1.5 years for a total of 3 assessments to allow evaluation of cognitive decline.\nThe primary endpoint for VITAL-Cog will be the change over time in GLOBAL COMPOSITE SCORE, calculated by averaging the z-scores for the component tests for each participant. However, we will also analyze the individual cognitive tests as additional secondary outcomes.\nThe two key secondary endpoints are change over time in the EPISODIC MEMORY SCORE combining z-scores of the immediate and delayed recalls of both the EBMT and the TICS 10-word list; and the EXECUTIVE FUNCTION SCORE, based on the z-scores of category fluency and OTMT.", 
            "measure": "Cognitive Decline", 
            "safety_issue": "No", 
            "time_frame": "5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01669915"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Brigham and Women's Hospital", 
            "investigator_full_name": "Jae Hee Kang", 
            "investigator_title": "Assistant Professor of Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Brigham and Women's Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institute on Aging (NIA)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Brigham and Women's Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}